Event: The Trump administration and Republicans in Congress failed to repeal and replace the Affordable Care Act in 2017. So what comes next?

These are tough times around the world when it comes to regulating flawed medicines that are banned from the marketplace. Last month, the Washington Post reported details from a DEA database of 76 billion opioid pills sold in the United States between 2006 and 2012, showing that some six companies distributed 75 percent of the pills during that period.

Are Democratic hopefuls offering sound ideas (Green New Deal, Universal Basic Income, Medicare-For-All) or economic illiteracy?

"The issue is patents," Nobel-prize winning economist Milton Friedman explained when asked in 2004 why he opposed drug reimportation, the practice of bringing back prescription drugs originally manufactured in the U.S. and exported to other countries to sale.